Clinical Study
Adequate Platelet Function Inhibition Confirmed by Two Inductive Agents Predicts Lower Recurrence of Ischemic Stroke/Transient Ischemic Attack
Table 2
Association of inhibited platelet aggregation with the recurrent ischemic stroke/TIA within a 3-month follow-up.
| | Inductive agent | Groups (MAR) | Ending (%) | No ending (%) | Numbers | value |
| | ADP | ≥35% | 16 (3.84) | 401 (96.16) | 417 | 0.0864 | | <35% | 2 (1.16) | 170 (98.84) | 172 | | AA | ≥35% | 8 (3.31) | 234 (96.69) | 242 | 0.7782 | | <35% | 10 (2.90) | 335 (97.10) | 345 | | ADP + AA | or | 18 (3.92) | 441 (96.08) | 459 | 0.0188 | | and | 0 (0.00) | 121 (100.00) | 121 |
|
|
